Organisation: EiRx

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

EIRX unit applies for liquidation

EIRX Therapeutics, the Cork-based drug discovery firm, has applied to put its Irish unit into liquidation.

business

EiRx requests share suspension

business

Group’s pre-tax loss narrows

business

EiRx funding package sufficient

business

Cancer research firm under threat

business

EiRx Therapeutics aims for share issue

Co-founder Hayes departs in EiRx shake-up

DR IAN HAYES, the chief executive and co-founder of EiRx Therapeutics, has left the Cork-based pharmaceutical company.

Fri, 19 Aug, 2005

Potential cancer drug patents

EiRx Therapeutics, the AIM-quoted drug discovery company based at Cork Airport Business Park, has filed patent applications for new drug candidates with potential value as treatments for a range of cancers, including colorectal and breast tumours.

Wed, 17 Aug, 2005

EiRx Therapeuticsin acquisition

EiRx Therapeutics, the Cork Airport business park-based drug discovery company that floated on London’s Alternative Investment Market (AIM) last year, has completed the acquisition of Auvation Ltd.

Thu, 11 Aug, 2005

EiRx ups stake in Scottish company

CANCER research firm EiRx Therapeutics has increased its stake in Scottish research business Auvation to 95%.

Fri, 13 May, 2005

EiRx Therapeutics increases stake

HEALTHCARE firm EiRx Therapeutics has increased its stake in Scottish cancer research company Auvation to 75.1%.

Thu, 07 Apr, 2005

Calyx to scoop €10m in flotation

MAURICE HEALY is in line for a €10 million pay day when his company Calyx floats on London’s Alternative Investment Market (AIM) next month.

Mon, 21 Feb, 2005

EiRx buys stake in Auvation

Ian Guider

Tue, 01 Feb, 2005

Cork research firm shares on market

Publicly-quoted pharmaceutical research company EiRx Therapeutics said venture capital group Billam, one of its major shareholders, would raise almost €500,000 from the sale of some of its stake.

Thu, 01 Apr, 2004

Drugs research firm’s shares surge 50%

SHARES in EiRx Therapeutics, the Cork-based pharmaceutical research company, surged almost 50% on their first day on London’s Alternative Investment Market yesterday.

Wed, 14 Jan, 2004

Cork company begins trading in London

Kinsale-based science research firm EiRx Therapeutics began trading in London today for the first time.

Tue, 13 Jan, 2004

Irish drug research company to list on AIM

A CORK drug research company will complete its journey from UCC start-up to the London Stock Exchange early next month.

Sat, 20 Dec, 2003